Vanguard Group Discloses Position in Mural Oncology

The Vanguard Group, Inc. has released a Form 8.3 under the Irish Takeover Panel Act concerning its position in Mural Oncology plc. The disclosure, dated July 17, 2025, indicates Vanguard's interests in Mural Oncology with a holding of 772,579 ordinary shares, equivalent to 4.47% of the company.

Vanguard reported no dealings in derivatives or options relating to the shares of Mural Oncology. Additionally, there were no agreements or understandings concerning the voting rights of the securities or future acquisitions. The company also confirmed that no indemnity or other dealing arrangements exist.

No supplemental Form 8 accompanies this disclosure, which specifies a minor sale of 16 shares at $2.49 each. This position disclosure aligns with Rule 8.3 of the Irish Takeover Panel, aiming for transparency in corporate acquisitions.